Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

Published:2011-08 Issue:12 Volume:47 Page:1890-1907
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Lin Tingting,Ding Zhiying,Li Nan,Xu Jiayun,Luo Guimin,Liu Junqiu,Shen Jiacong

Funder

the Natural Science Foundation of China

NSFC

the National Basic Research Program

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo;Walczak;Nat Med,1999

2. The receptor for the cytotoxic ligand TRAIL;Pan;Science,1997

3. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL;Walczak;EMBO J,1997

4. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family;Degli-Esposti;J Exp Med,1997

5. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain;Degli-Esposti;Immunity,1997

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study;British Journal of Clinical Pharmacology;2024-08-07

2. Mechanisms and Advances of Epigenetic Regulation in Cardiovascular Disease;Frontiers in Bioscience-Landmark;2024-05-28

3. Effect of zinc and selenium on breast cancer risk: a NHANES cross-sectional study and mediation analysis;2024-02-13

4. Luminol-conjugated cyclodextrin biological nanoparticles for the treatment of severe burn-induced intestinal barrier disruption;BURNS TRAUMA;2024

5. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation;Antioxidants;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3